• norsk
    • English
  • norsk 
    • norsk
    • English
  • Logg inn
Blar i på forfatter 
  •   Hjem
  • Blar i på forfatter
  •   Hjem
  • Blar i på forfatter
JavaScript is disabled for your browser. Some features of this site may not work without it.

Blar i Bergen Open Research Archive på forfatter "Seo, Mikyung Kelly"

  • 0-9
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z
  • Æ
  • Ø
  • Å

Sorter på:

Rekkefølge:

Resultater:

Viser treff 1-5 av 5

  • Tittel
  • Utgivelsesdato
  • Registreringsdato
  • Forfatter
  • stigende
  • synkende
  • 5
  • 10
  • 20
  • 40
  • 60
  • 80
  • 100
    • Cancer Biomarkers: Ethics, Economics and Society 

      Blanchard, Anne; Strand, Roger; Cairns, John Alexander; Tranvåg, Eirik Joakim; Norheim, Ole Frithjof; Seo, Mikyung Kelly; Wik, Elisabeth; Engen, Caroline Benedicte Nitter; Blasimme, Alessandro; Fleck, Leonard M. (Book, 2017)
    • Has the development of cancer biomarkers to guide treatment improved health outcomes? 

      Luís, Ana Beatriz Mateus D'Avó; Seo, Mikyung Kelly (Journal article; Peer reviewed, 2021)
      During the last decade, testing the patient’s biomarker status prior to the administration of corresponding co-dependent therapies has been emerging in clinical practice. These biomarker-guided therapies have promoted the ...
    • How are we evaluating the cost-effectiveness of companion biomarkers for targeted cancer therapies? A systematic review 

      Seo, Mikyung Kelly; Cairns, John Alexander (Journal article; Peer reviewed, 2021)
      Background Despite the increasing economic assessment of biomarker-guided therapies, no clear agreement exists whether existing methods are sufficient or whether different methods might produce different cost-effectiveness ...
    • HSP27 Expression as a Novel Predictive Biomarker for Bevacizumab: is it Cost Effective? 

      Seo, Mikyung Kelly; Straume, Oddbjørn; Akslen, Lars A.; Cairns, John Alexander (Journal article; Peer reviewed, 2020)
      Background: Despite the extensive use of bevacizumab in a range of oncology indications, the US FDA revoked its approval for breast cancers, and multiple negative trials in several solid malignancies have been reported, ...
    • A Practical Guide to Modeling and Conducting a Cost-Effectiveness Analysis of Companion Biomarker Tests for Targeted Therapies Using R: Tutorial Paper 

      Seo, Mikyung Kelly; Strong, Mark (Journal article; Peer reviewed, 2021)
      Despite the increasing number of potential biomarkers identified in laboratories and reported in much literature, the adoption of biomarkers routinely available in clinical practice to inform treatment decisions is very ...

      Kontakt oss | Gi tilbakemelding

      Personvernerklæring
      DSpace software copyright © 2002-2019  DuraSpace

      Levert av  Unit
       

       

      Bla i

      Hele arkivetDelarkiv og samlingerUtgivelsesdatoForfattereTitlerEmneordDokumenttyperTidsskrifter

      Min side

      Logg inn

      Kontakt oss | Gi tilbakemelding

      Personvernerklæring
      DSpace software copyright © 2002-2019  DuraSpace

      Levert av  Unit